Chametherpay-induced nausea and vomitting
Conditions
Interventions
Experimental group:Fire Needle
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as malignant tumor by pathology or cytology, or imaging combined with specific tumor markers; 2. Has received or is receiving a combination of highly emetogenic chemotherapy containing cisplatin, cyclophosphamide + anthracycline (AC regimen); 3. Antiemetics are: 5HT3 receptor antagonist, NK1 receptor; 4. The general condition is good, the Karnofasky score is >=60, and the estimated survival period is >=5 months; 5. Aged 18 to 75 years; 6. Those without severe cardiovascular, liver, kidney, bone marrow insufficiency and normal coagulation function; 7. Sign the informed consent form and be willing to accept the treatment of this program.
Exclusion criteria
Exclusion criteria: 1. The patient has received acupuncture and moxibustion for other diseases from admission to chemotherapy; 2. Patients with nausea and vomiting due to brain metastasis or limb metastasis, or nausea and vomiting due to electrolyte imbalance and other systemic diseases (such as severe diabetes); 3. Patients with severe other infectious diseases, liver, kidney and heart insufficiency; 4. Combined with intellectual disability or a history of mental illness and unable to conduct self-assessment; 5. Patients with concurrent radiotherapy during chemotherapy; 6. Those who cannot tolerate fire needles due to allergies, tension and other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multinational Association of Supportive Care in Cancer Memory Analyzer Tool;No nausea rate;Complete control rate;total control rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and Depression Scale;Simplified Nutritional Appetite Questionnaire;Nausea and Vomiting Adverse Reaction Terminology Rating; | — |
Countries
China
Contacts
Public ContactLin Guohua
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed